nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisacodyl—Abdominal rigidity—Sorafenib—kidney cancer	0.213	0.213	CcSEcCtD
Bisacodyl—Haematochezia—Pazopanib—kidney cancer	0.0369	0.0369	CcSEcCtD
Bisacodyl—Blood in stool—Capecitabine—kidney cancer	0.033	0.033	CcSEcCtD
Bisacodyl—Haematochezia—Erlotinib—kidney cancer	0.0281	0.0281	CcSEcCtD
Bisacodyl—Haematochezia—Sunitinib—kidney cancer	0.0244	0.0244	CcSEcCtD
Bisacodyl—Haematochezia—Capecitabine—kidney cancer	0.0134	0.0134	CcSEcCtD
Bisacodyl—Abdominal cramps—Vincristine—kidney cancer	0.0123	0.0123	CcSEcCtD
Bisacodyl—Colitis—Erlotinib—kidney cancer	0.0109	0.0109	CcSEcCtD
Bisacodyl—Dehydration—Temsirolimus—kidney cancer	0.0107	0.0107	CcSEcCtD
Bisacodyl—Dehydration—Pazopanib—kidney cancer	0.01	0.01	CcSEcCtD
Bisacodyl—Haematochezia—Doxorubicin—kidney cancer	0.00866	0.00866	CcSEcCtD
Bisacodyl—Dehydration—Everolimus—kidney cancer	0.00793	0.00793	CcSEcCtD
Bisacodyl—Dehydration—Erlotinib—kidney cancer	0.00765	0.00765	CcSEcCtD
Bisacodyl—Immune system disorder—Temsirolimus—kidney cancer	0.00716	0.00716	CcSEcCtD
Bisacodyl—Malnutrition—Temsirolimus—kidney cancer	0.0069	0.0069	CcSEcCtD
Bisacodyl—Dehydration—Sorafenib—kidney cancer	0.00688	0.00688	CcSEcCtD
Bisacodyl—Dehydration—Sunitinib—kidney cancer	0.00662	0.00662	CcSEcCtD
Bisacodyl—Malnutrition—Pazopanib—kidney cancer	0.0065	0.0065	CcSEcCtD
Bisacodyl—Anorectal discomfort—Doxorubicin—kidney cancer	0.00638	0.00638	CcSEcCtD
Bisacodyl—Colitis—Paclitaxel—kidney cancer	0.00633	0.00633	CcSEcCtD
Bisacodyl—Angioedema—Temsirolimus—kidney cancer	0.00631	0.00631	CcSEcCtD
Bisacodyl—Muscle spasms—Pazopanib—kidney cancer	0.00625	0.00625	CcSEcCtD
Bisacodyl—Abdominal discomfort—Sorafenib—kidney cancer	0.00613	0.00613	CcSEcCtD
Bisacodyl—Abdominal discomfort—Sunitinib—kidney cancer	0.0059	0.0059	CcSEcCtD
Bisacodyl—Syncope—Pazopanib—kidney cancer	0.00583	0.00583	CcSEcCtD
Bisacodyl—Loss of consciousness—Pazopanib—kidney cancer	0.00572	0.00572	CcSEcCtD
Bisacodyl—Anaphylactic shock—Temsirolimus—kidney cancer	0.00563	0.00563	CcSEcCtD
Bisacodyl—Dehydration—Vincristine—kidney cancer	0.0056	0.0056	CcSEcCtD
Bisacodyl—Nervous system disorder—Temsirolimus—kidney cancer	0.00552	0.00552	CcSEcCtD
Bisacodyl—Immune system disorder—Everolimus—kidney cancer	0.00533	0.00533	CcSEcCtD
Bisacodyl—Shock—Pazopanib—kidney cancer	0.00522	0.00522	CcSEcCtD
Bisacodyl—Nervous system disorder—Pazopanib—kidney cancer	0.0052	0.0052	CcSEcCtD
Bisacodyl—Colitis—Capecitabine—kidney cancer	0.00519	0.00519	CcSEcCtD
Bisacodyl—Malnutrition—Everolimus—kidney cancer	0.00513	0.00513	CcSEcCtD
Bisacodyl—Malnutrition—Erlotinib—kidney cancer	0.00495	0.00495	CcSEcCtD
Bisacodyl—Muscle spasms—Everolimus—kidney cancer	0.00494	0.00494	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00486	0.00486	CcSEcCtD
Bisacodyl—Angioedema—Everolimus—kidney cancer	0.00469	0.00469	CcSEcCtD
Bisacodyl—Immune system disorder—Sorafenib—kidney cancer	0.00462	0.00462	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Temsirolimus—kidney cancer	0.00461	0.00461	CcSEcCtD
Bisacodyl—Syncope—Everolimus—kidney cancer	0.0046	0.0046	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Pazopanib—kidney cancer	0.00458	0.00458	CcSEcCtD
Bisacodyl—Loss of consciousness—Everolimus—kidney cancer	0.00451	0.00451	CcSEcCtD
Bisacodyl—Malnutrition—Sorafenib—kidney cancer	0.00446	0.00446	CcSEcCtD
Bisacodyl—Abdominal pain—Temsirolimus—kidney cancer	0.00445	0.00445	CcSEcCtD
Bisacodyl—Immune system disorder—Sunitinib—kidney cancer	0.00445	0.00445	CcSEcCtD
Bisacodyl—Dehydration—Paclitaxel—kidney cancer	0.00445	0.00445	CcSEcCtD
Bisacodyl—Syncope—Erlotinib—kidney cancer	0.00444	0.00444	CcSEcCtD
Bisacodyl—Loss of consciousness—Erlotinib—kidney cancer	0.00435	0.00435	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Pazopanib—kidney cancer	0.00434	0.00434	CcSEcCtD
Bisacodyl—Cramp muscle—Paclitaxel—kidney cancer	0.00431	0.00431	CcSEcCtD
Bisacodyl—Malnutrition—Sunitinib—kidney cancer	0.00429	0.00429	CcSEcCtD
Bisacodyl—Muscle spasms—Sorafenib—kidney cancer	0.00428	0.00428	CcSEcCtD
Bisacodyl—Abdominal pain—Pazopanib—kidney cancer	0.0042	0.0042	CcSEcCtD
Bisacodyl—Hypersensitivity—Temsirolimus—kidney cancer	0.00415	0.00415	CcSEcCtD
Bisacodyl—Muscle spasms—Sunitinib—kidney cancer	0.00412	0.00412	CcSEcCtD
Bisacodyl—Shock—Everolimus—kidney cancer	0.00412	0.00412	CcSEcCtD
Bisacodyl—Nervous system disorder—Everolimus—kidney cancer	0.00411	0.00411	CcSEcCtD
Bisacodyl—Angioedema—Sorafenib—kidney cancer	0.00407	0.00407	CcSEcCtD
Bisacodyl—Syncope—Sorafenib—kidney cancer	0.004	0.004	CcSEcCtD
Bisacodyl—Shock—Erlotinib—kidney cancer	0.00398	0.00398	CcSEcCtD
Bisacodyl—Nervous system disorder—Erlotinib—kidney cancer	0.00397	0.00397	CcSEcCtD
Bisacodyl—Angioedema—Sunitinib—kidney cancer	0.00392	0.00392	CcSEcCtD
Bisacodyl—Loss of consciousness—Sorafenib—kidney cancer	0.00392	0.00392	CcSEcCtD
Bisacodyl—Diarrhoea—Temsirolimus—kidney cancer	0.00385	0.00385	CcSEcCtD
Bisacodyl—Dizziness—Temsirolimus—kidney cancer	0.00373	0.00373	CcSEcCtD
Bisacodyl—Dehydration—Capecitabine—kidney cancer	0.00365	0.00365	CcSEcCtD
Bisacodyl—Anaphylactic shock—Sorafenib—kidney cancer	0.00364	0.00364	CcSEcCtD
Bisacodyl—Diarrhoea—Pazopanib—kidney cancer	0.00363	0.00363	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Everolimus—kidney cancer	0.00362	0.00362	CcSEcCtD
Bisacodyl—Vomiting—Temsirolimus—kidney cancer	0.00358	0.00358	CcSEcCtD
Bisacodyl—Shock—Sorafenib—kidney cancer	0.00358	0.00358	CcSEcCtD
Bisacodyl—Immune system disorder—Gemcitabine—kidney cancer	0.00357	0.00357	CcSEcCtD
Bisacodyl—Nervous system disorder—Sorafenib—kidney cancer	0.00357	0.00357	CcSEcCtD
Bisacodyl—Headache—Temsirolimus—kidney cancer	0.00353	0.00353	CcSEcCtD
Bisacodyl—Dizziness—Pazopanib—kidney cancer	0.00351	0.00351	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00349	0.00349	CcSEcCtD
Bisacodyl—Shock—Sunitinib—kidney cancer	0.00344	0.00344	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Vinblastine—kidney cancer	0.00344	0.00344	CcSEcCtD
Bisacodyl—Nervous system disorder—Sunitinib—kidney cancer	0.00343	0.00343	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Everolimus—kidney cancer	0.00343	0.00343	CcSEcCtD
Bisacodyl—Vomiting—Pazopanib—kidney cancer	0.00337	0.00337	CcSEcCtD
Bisacodyl—Colitis—Doxorubicin—kidney cancer	0.00335	0.00335	CcSEcCtD
Bisacodyl—Nausea—Temsirolimus—kidney cancer	0.00335	0.00335	CcSEcCtD
Bisacodyl—Abdominal pain—Vinblastine—kidney cancer	0.00333	0.00333	CcSEcCtD
Bisacodyl—Headache—Pazopanib—kidney cancer	0.00332	0.00332	CcSEcCtD
Bisacodyl—Abdominal pain—Everolimus—kidney cancer	0.00331	0.00331	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Erlotinib—kidney cancer	0.00331	0.00331	CcSEcCtD
Bisacodyl—Abdominal discomfort—Capecitabine—kidney cancer	0.00325	0.00325	CcSEcCtD
Bisacodyl—Abdominal pain—Erlotinib—kidney cancer	0.0032	0.0032	CcSEcCtD
Bisacodyl—Nausea—Pazopanib—kidney cancer	0.00315	0.00315	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00314	0.00314	CcSEcCtD
Bisacodyl—Hypersensitivity—Vinblastine—kidney cancer	0.0031	0.0031	CcSEcCtD
Bisacodyl—Hypersensitivity—Everolimus—kidney cancer	0.00309	0.00309	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00302	0.00302	CcSEcCtD
Bisacodyl—Immune system disorder—Paclitaxel—kidney cancer	0.00299	0.00299	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Sorafenib—kidney cancer	0.00297	0.00297	CcSEcCtD
Bisacodyl—Anaphylactic shock—Vincristine—kidney cancer	0.00296	0.00296	CcSEcCtD
Bisacodyl—Nervous system disorder—Vincristine—kidney cancer	0.0029	0.0029	CcSEcCtD
Bisacodyl—Malnutrition—Paclitaxel—kidney cancer	0.00288	0.00288	CcSEcCtD
Bisacodyl—Diarrhoea—Vinblastine—kidney cancer	0.00288	0.00288	CcSEcCtD
Bisacodyl—Abdominal pain—Sorafenib—kidney cancer	0.00288	0.00288	CcSEcCtD
Bisacodyl—Diarrhoea—Everolimus—kidney cancer	0.00287	0.00287	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Sunitinib—kidney cancer	0.00286	0.00286	CcSEcCtD
Bisacodyl—Anaphylactic shock—Gemcitabine—kidney cancer	0.00281	0.00281	CcSEcCtD
Bisacodyl—Dizziness—Vinblastine—kidney cancer	0.00278	0.00278	CcSEcCtD
Bisacodyl—Dizziness—Everolimus—kidney cancer	0.00277	0.00277	CcSEcCtD
Bisacodyl—Muscle spasms—Paclitaxel—kidney cancer	0.00277	0.00277	CcSEcCtD
Bisacodyl—Abdominal pain—Sunitinib—kidney cancer	0.00277	0.00277	CcSEcCtD
Bisacodyl—Diarrhoea—Erlotinib—kidney cancer	0.00277	0.00277	CcSEcCtD
Bisacodyl—Nervous system disorder—Gemcitabine—kidney cancer	0.00275	0.00275	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00271	0.00271	CcSEcCtD
Bisacodyl—Hypersensitivity—Sorafenib—kidney cancer	0.00268	0.00268	CcSEcCtD
Bisacodyl—Vomiting—Vinblastine—kidney cancer	0.00267	0.00267	CcSEcCtD
Bisacodyl—Dizziness—Erlotinib—kidney cancer	0.00267	0.00267	CcSEcCtD
Bisacodyl—Vomiting—Everolimus—kidney cancer	0.00266	0.00266	CcSEcCtD
Bisacodyl—Headache—Vinblastine—kidney cancer	0.00264	0.00264	CcSEcCtD
Bisacodyl—Angioedema—Paclitaxel—kidney cancer	0.00263	0.00263	CcSEcCtD
Bisacodyl—Headache—Everolimus—kidney cancer	0.00263	0.00263	CcSEcCtD
Bisacodyl—Abdominal pain—Dactinomycin—kidney cancer	0.00262	0.00262	CcSEcCtD
Bisacodyl—Syncope—Paclitaxel—kidney cancer	0.00258	0.00258	CcSEcCtD
Bisacodyl—Hypersensitivity—Sunitinib—kidney cancer	0.00258	0.00258	CcSEcCtD
Bisacodyl—Vomiting—Erlotinib—kidney cancer	0.00257	0.00257	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Vincristine—kidney cancer	0.00256	0.00256	CcSEcCtD
Bisacodyl—Headache—Erlotinib—kidney cancer	0.00253	0.00253	CcSEcCtD
Bisacodyl—Loss of consciousness—Paclitaxel—kidney cancer	0.00253	0.00253	CcSEcCtD
Bisacodyl—Nausea—Vinblastine—kidney cancer	0.0025	0.0025	CcSEcCtD
Bisacodyl—Nausea—Everolimus—kidney cancer	0.00249	0.00249	CcSEcCtD
Bisacodyl—Diarrhoea—Sorafenib—kidney cancer	0.00249	0.00249	CcSEcCtD
Bisacodyl—Immune system disorder—Capecitabine—kidney cancer	0.00245	0.00245	CcSEcCtD
Bisacodyl—Hypersensitivity—Dactinomycin—kidney cancer	0.00244	0.00244	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00242	0.00242	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Vincristine—kidney cancer	0.00242	0.00242	CcSEcCtD
Bisacodyl—Dizziness—Sorafenib—kidney cancer	0.00241	0.00241	CcSEcCtD
Bisacodyl—Nausea—Erlotinib—kidney cancer	0.0024	0.0024	CcSEcCtD
Bisacodyl—Diarrhoea—Sunitinib—kidney cancer	0.00239	0.00239	CcSEcCtD
Bisacodyl—Malnutrition—Capecitabine—kidney cancer	0.00236	0.00236	CcSEcCtD
Bisacodyl—Dehydration—Doxorubicin—kidney cancer	0.00235	0.00235	CcSEcCtD
Bisacodyl—Anaphylactic shock—Paclitaxel—kidney cancer	0.00235	0.00235	CcSEcCtD
Bisacodyl—Abdominal pain—Vincristine—kidney cancer	0.00234	0.00234	CcSEcCtD
Bisacodyl—Dizziness—Sunitinib—kidney cancer	0.00231	0.00231	CcSEcCtD
Bisacodyl—Shock—Paclitaxel—kidney cancer	0.00231	0.00231	CcSEcCtD
Bisacodyl—Vomiting—Sorafenib—kidney cancer	0.00231	0.00231	CcSEcCtD
Bisacodyl—Nervous system disorder—Paclitaxel—kidney cancer	0.00231	0.00231	CcSEcCtD
Bisacodyl—Headache—Sorafenib—kidney cancer	0.00228	0.00228	CcSEcCtD
Bisacodyl—Muscle spasms—Capecitabine—kidney cancer	0.00227	0.00227	CcSEcCtD
Bisacodyl—Diarrhoea—Dactinomycin—kidney cancer	0.00227	0.00227	CcSEcCtD
Bisacodyl—Vomiting—Sunitinib—kidney cancer	0.00223	0.00223	CcSEcCtD
Bisacodyl—Headache—Sunitinib—kidney cancer	0.00219	0.00219	CcSEcCtD
Bisacodyl—Hypersensitivity—Vincristine—kidney cancer	0.00218	0.00218	CcSEcCtD
Bisacodyl—Nausea—Sorafenib—kidney cancer	0.00216	0.00216	CcSEcCtD
Bisacodyl—Syncope—Capecitabine—kidney cancer	0.00212	0.00212	CcSEcCtD
Bisacodyl—Vomiting—Dactinomycin—kidney cancer	0.00211	0.00211	CcSEcCtD
Bisacodyl—Nausea—Sunitinib—kidney cancer	0.00208	0.00208	CcSEcCtD
Bisacodyl—Loss of consciousness—Capecitabine—kidney cancer	0.00208	0.00208	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00203	0.00203	CcSEcCtD
Bisacodyl—Diarrhoea—Vincristine—kidney cancer	0.00203	0.00203	CcSEcCtD
Bisacodyl—Nausea—Dactinomycin—kidney cancer	0.00197	0.00197	CcSEcCtD
Bisacodyl—Dizziness—Vincristine—kidney cancer	0.00196	0.00196	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00192	0.00192	CcSEcCtD
Bisacodyl—Diarrhoea—Gemcitabine—kidney cancer	0.00192	0.00192	CcSEcCtD
Bisacodyl—Shock—Capecitabine—kidney cancer	0.0019	0.0019	CcSEcCtD
Bisacodyl—Nervous system disorder—Capecitabine—kidney cancer	0.00189	0.00189	CcSEcCtD
Bisacodyl—Vomiting—Vincristine—kidney cancer	0.00188	0.00188	CcSEcCtD
Bisacodyl—Abdominal pain—Paclitaxel—kidney cancer	0.00186	0.00186	CcSEcCtD
Bisacodyl—Headache—Vincristine—kidney cancer	0.00185	0.00185	CcSEcCtD
Bisacodyl—Vomiting—Gemcitabine—kidney cancer	0.00179	0.00179	CcSEcCtD
Bisacodyl—Headache—Gemcitabine—kidney cancer	0.00176	0.00176	CcSEcCtD
Bisacodyl—Nausea—Vincristine—kidney cancer	0.00176	0.00176	CcSEcCtD
Bisacodyl—Hypersensitivity—Paclitaxel—kidney cancer	0.00173	0.00173	CcSEcCtD
Bisacodyl—Nausea—Gemcitabine—kidney cancer	0.00167	0.00167	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00167	0.00167	CcSEcCtD
Bisacodyl—Diarrhoea—Paclitaxel—kidney cancer	0.00161	0.00161	CcSEcCtD
Bisacodyl—Immune system disorder—Doxorubicin—kidney cancer	0.00158	0.00158	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Capecitabine—kidney cancer	0.00158	0.00158	CcSEcCtD
Bisacodyl—Dizziness—Paclitaxel—kidney cancer	0.00155	0.00155	CcSEcCtD
Bisacodyl—Abdominal pain—Capecitabine—kidney cancer	0.00153	0.00153	CcSEcCtD
Bisacodyl—Malnutrition—Doxorubicin—kidney cancer	0.00152	0.00152	CcSEcCtD
Bisacodyl—Vomiting—Paclitaxel—kidney cancer	0.0015	0.0015	CcSEcCtD
Bisacodyl—Headache—Paclitaxel—kidney cancer	0.00147	0.00147	CcSEcCtD
Bisacodyl—Muscle spasms—Doxorubicin—kidney cancer	0.00147	0.00147	CcSEcCtD
Bisacodyl—Hypersensitivity—Capecitabine—kidney cancer	0.00142	0.00142	CcSEcCtD
Bisacodyl—Nausea—Paclitaxel—kidney cancer	0.0014	0.0014	CcSEcCtD
Bisacodyl—Syncope—Doxorubicin—kidney cancer	0.00137	0.00137	CcSEcCtD
Bisacodyl—Loss of consciousness—Doxorubicin—kidney cancer	0.00134	0.00134	CcSEcCtD
Bisacodyl—Diarrhoea—Capecitabine—kidney cancer	0.00132	0.00132	CcSEcCtD
Bisacodyl—Dizziness—Capecitabine—kidney cancer	0.00128	0.00128	CcSEcCtD
Bisacodyl—Anaphylactic shock—Doxorubicin—kidney cancer	0.00124	0.00124	CcSEcCtD
Bisacodyl—Vomiting—Capecitabine—kidney cancer	0.00123	0.00123	CcSEcCtD
Bisacodyl—Shock—Doxorubicin—kidney cancer	0.00122	0.00122	CcSEcCtD
Bisacodyl—Nervous system disorder—Doxorubicin—kidney cancer	0.00122	0.00122	CcSEcCtD
Bisacodyl—Headache—Capecitabine—kidney cancer	0.00121	0.00121	CcSEcCtD
Bisacodyl—Nausea—Capecitabine—kidney cancer	0.00115	0.00115	CcSEcCtD
Bisacodyl—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00107	0.00107	CcSEcCtD
Bisacodyl—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00102	0.00102	CcSEcCtD
Bisacodyl—Abdominal pain—Doxorubicin—kidney cancer	0.000983	0.000983	CcSEcCtD
Bisacodyl—Hypersensitivity—Doxorubicin—kidney cancer	0.000916	0.000916	CcSEcCtD
Bisacodyl—Diarrhoea—Doxorubicin—kidney cancer	0.000851	0.000851	CcSEcCtD
Bisacodyl—Dizziness—Doxorubicin—kidney cancer	0.000823	0.000823	CcSEcCtD
Bisacodyl—Vomiting—Doxorubicin—kidney cancer	0.000791	0.000791	CcSEcCtD
Bisacodyl—Headache—Doxorubicin—kidney cancer	0.000779	0.000779	CcSEcCtD
Bisacodyl—Nausea—Doxorubicin—kidney cancer	0.000739	0.000739	CcSEcCtD
